Mirae Asset Global ETFs Holdings’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$966K Buy
10,068
+284
+3% +$29.1K ﹤0.01% 1645
2026
Q1
$1.07M Buy
9,784
+96
+1% +$9.15K ﹤0.01% 1493
2025
Q4
$786K Sell
9,688
-7
-0.1% -$603 ﹤0.01% 1654
2025
Q3
$848K Sell
9,695
-1,742
-15% -$156K ﹤0.01% 1580
2025
Q2
$950K Sell
11,437
-641
-5% -$53.6K ﹤0.01% 1469
2025
Q1
$1.01M Buy
12,078
+539
+5% +$50.1K ﹤0.01% 1494
2024
Q4
$1.06M Buy
11,539
+454
+4% +$43.7K ﹤0.01% 1509
2024
Q3
$1.03M Buy
11,085
+1,323
+14% +$115K ﹤0.01% 1527
2024
Q2
$803K Buy
+9,762
New +$717K ﹤0.01% 1579

Other funds holding LMAT

Mirae Asset Global ETFs Holdings's LMAT Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its LeMaitre Vascular (LMAT) stake by 2.9% in Q2 2026, buying an estimated $29.1K and bringing the position to 10,068 shares worth $966K. The position accounts for ﹤0.01% of the portfolio, ranked #1645.

Mirae Asset Global ETFs Holdings first reported a position in LMAT in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.07M in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 10,068 shares of LeMaitre Vascular worth $966K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 284 LeMaitre Vascular shares in Q2 2026, an estimated $29.1K.
  • LeMaitre Vascular made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1645 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in LeMaitre Vascular in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's LeMaitre Vascular position peaked at $1.07M in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.